Mr. Li, a 42-year-old man with a slight build, had a sudden heart attack and a stent was placed. In the post-operative examination, he was found to have abnormal lipids reading (LDL-C: 4.68 mmol/L), and was required by his doctor to control his blood lipids level and to have the anticoagulation treatment. Mr. Li was rather confused. Why is lipid control necessary for the treatment of heart attack? How to lower lipids and what tests are needed? How low should the level be maintained at?
Xiao Wang was especially happy at the banquet. He ate a large amount of BBQ food and drank 250-300 grams of 53-degree liquor. Less than 2 hours after the dinner, Xiao Wang started to feel severe stubbing pain in his abdomen with excessive sweating.
Heart failure (HF) is a heart condition with close-to-cancer five-year survival rate that, however, tend to be neglected in our life. More than 10 million Chinese people are diagnosed with HF, patients aged 70 and above accounting for over 10%.
SAHZU always focuses on catering to patients’ needs. With an endeavor to “work out solutions to some certain major diseases”, SAHZU now starts to take early actions for health promotion and disease prevention. The Medical Genetics Department is thus founded at SAHZU, with a goal to provide advanced clinical services in early diagnosis, birth defect prevention, and diagnosis and treatment of complicated medical conditions from a molecular medicine approach.
Chair of SAHZU Labor Union Ms. WANG Sihua is awarded the honor of "Best Doctor" of Year 2021 by the National Health Commission and the Publicity Department of China, on the occasion of the fourth Chinese Doctor Day on August 19, for her 5 years' outstanding work in transforming the People's Hospital of Taijiang County into a trusted and regionally renowned medical provider.
After multiple rounds of scrutinous reviewing, National Natural Science Foundation of China releases its granted programs for year 2021 Wednesday. 159 programs, including 7 major programs, applied by SAHZU physicians and scientists from 35 departments or research institutes are in the list, the number of which rank the second among all Chinese hospitals, marking another breakthrough in SAHZU’s scientific research efforts.
China Valve (Hangzhou) 2021 held its closing ceremony on Sunday. Over 400 speakers and moderators attended the conference online or on-site. More than 1500 audience registered for the event. The highlight of the conference -- 117 cases demonstration attracted over 800k total views from 23 countries and regions in 7 days.
After ten years' development, the "Guangji Ark" now has 6000 registered volunteers, with an average age of 60, on 22 kinds of jobs, and has served nearly 17 million patients.
Recently, the research team led by Prof. SHEN Huahao and Prof. YING Songmin from the Key Laboratory of Respiratory Disease of Zhejiang Province, Department of Respiratory and Critical Care Medicine of SAHZU, discovered that eosinophilic inflammation promotes metastatic tumor growth. This study offers a potential target for the therapy of metastatic disease. The findings were published in the journal Science Advances on May 26.
June 17, SAHZU Neurosurgeon Prof. LIU Fengqiang remotely manipulates the stereotactic neurosurgery robot, Remebot, 200 kilometers away in Songyang Hospital of Li Shui City through a 5G network, and evacuates the intracerebral hematoma of a patient there. This remarkable achievement set a milestone of establishing China's first 5G-based digital neurosurgery operating theater.
A new study led by SAHZU researchers has identified ways by which some microbes might influence cancer immunotherapy, suggesting a potential microbial-based adjuvant approach to improve the responsiveness of immunotherapy. Their results were published in Cell1 in March 2024.
Italian surgeons Drs. Michele Cricrì and Federico Mongardini and Mexican surgeon Dr. Mitre Reyes have recently completed a three-month clinical training program at SAHZU Colorectal Surgery, as the second group of trainees of International Colorectal Surgery Training Academy of China (ICSTAC).
Dr. Lim Shin Hoei is an anesthesiologist from Penang, Malaysia. She was trained at SAHZU for trans-esophageal echocardiogram (TEE) and cardiothoracic anesthesia for six months. Congratulation to Dr. Lim!